Trials / Completed
CompletedNCT00552773
Pilot Study to Determine Efficacy of Cyclamen Europaeum Extract Nasal Spray in Patients With Acute Sinusitis
A Randomized, Double-blind, Placebo Controlled, Parallel Group Trial of Cyclamen Europaeum Extract Nasal Spray 10% (v/v) in the Treatment of Subjects With Acute Sinusitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of Cyclamen europaeum extract 10 % (v/v) compared to placebo in subjects with acute sinusitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclamen Europaeum | Nasal spray 10% (V/V),one spray per nostril daily for 7 days. |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-09-01
- Completion
- 2009-12-01
- First posted
- 2007-11-02
- Last updated
- 2013-06-04
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00552773. Inclusion in this directory is not an endorsement.